ArticleNature communications2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.
Radia M Johnson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papertrialcites it